American Drug Giant Makes Secret Bid for Struggling Rival: Report

U.S. pharmaceutical giant Pfizer (PFE) is considering to buy Britain’s struggling drug maker AstraZeneca for $101 billion, Sunday Times reported. The paper cited a variety of sources saying that “informal conversations” about a possible tie-up had taken place but that AstraZeneca, Britain’s second-biggest pharmaceuticals group, had rejected the offer with no discussions currently underway. “As […] View the full post at: American Drug Giant Makes Secret Bid for Struggling Rival: Report Related posts: Warner Chilcott to Announce a $3B Acquisition of Procter & Gamble’s Drug Unit HGSI’s Lupus Drug Shows Great Potential A Drug Stock With Potential For Solid Gain